BioInsights℠

Thematic Reports

Piper Sandler’s thematic BioInsights reports dive deep into a diverse array of disease pathways, indications of interest, and novel therapeutic modalities. 

The reports explore current and emerging competitive landscapes, and provide detailed profiles of key public and private players in each space – reviewing relevant pipeline and marketed assets, available clinical data and upcoming catalysts of interest.

 
32 3,679 683
  Thematic reports*   Pages*   Company profiles*
23+ 144 27
  Topics covered*   Average pages
  per report**
  Average companies
  profiled per report**

Learn More

Access market-driven and actionable insights.

Contact your Piper Sandler representative to receive thematic reports.

Access Now

Previous Topics Have Included:

  • AI in biopharma
  • Cell therapy
  • Cystic fibrosis
  • Engineered cytokines
  • Epilepsy
  • Gastrointestinal disorders
  • Gene editing
  • Generics and biosimilars
  • Gene therapy
  • Hepatitis B
  • Medical dermatology
  • Movement disorders
  • Oncology
  • Pain
  • Precision cardiovascular medicine
  • Protein degradation
  • Psychiatry and mood disorders
  • Renal disorders
  • RNA therapies
  • Sickle cell disease
  • TGF-beta
  • Therapeutic cannabis
  • Women’s and men’s health